$1.97 Billion is the total value of MEITAV INVESTMENT HOUSE LTD's 339 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VBIV | VBI VACCINES INC | $3,823,000 | -18.0% | 1,092,196 | 0.0% | 0.20% | -28.3% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $2,652,000 | -39.1% | 476,190 | 0.0% | 0.14% | -47.1% | |
| CAMT | CAMTEK LTDord | $2,409,000 | +18.0% | 356,890 | 0.0% | 0.12% | +3.4% | |
| CYRN | CYREN LTD | $901,000 | -6.0% | 383,472 | 0.0% | 0.05% | -17.9% | |
| PTNR | PARTNER COMMUNICATIONS CO LTadr | $770,000 | -25.5% | 167,896 | 0.0% | 0.04% | -35.0% | |
| GS | GOLDMAN SACHS GROUP INC | $610,000 | -1.9% | 2,430 | 0.0% | 0.03% | -13.9% | |
| TMUS | T MOBILE US INC | $610,000 | -5.3% | 10,000 | 0.0% | 0.03% | -18.4% | |
| NKE | NIKE INCcl b | $532,000 | +5.6% | 8,000 | 0.0% | 0.03% | -6.9% | |
| TAP | MOLSON COORS BREWING COcl b | $377,000 | -8.0% | 5,000 | 0.0% | 0.02% | -20.8% | |
| AZN | ASTRAZENECA PLCsponsored adr | $350,000 | +2.6% | 10,000 | 0.0% | 0.02% | -10.0% | |
| RDSA | ROYAL DUTCH SHELL PLCspons adr a | $319,000 | -4.2% | 5,000 | 0.0% | 0.02% | -15.8% | |
| UPS | UNITED PARCEL SERVICE INCcl b | $314,000 | -12.0% | 3,000 | 0.0% | 0.02% | -23.8% | |
| SHY | ISHARES TR1 3 yr treas bd | $251,000 | -0.4% | 3,000 | 0.0% | 0.01% | -13.3% | |
| RDHL | REDHILL BIOPHARMA LTDsponsored ads | $247,000 | +1.2% | 48,000 | 0.0% | 0.01% | -7.1% | |
| GIS | GENERAL MLS INC | $225,000 | -24.5% | 5,000 | 0.0% | 0.01% | -35.3% | |
| TEF | TELEFONICA S Asponsored adr | $98,000 | +1.0% | 10,000 | 0.0% | 0.01% | -16.7% | |
| EVGN | EVOGENE LTD | $63,000 | +3.3% | 19,869 | 0.0% | 0.00% | -25.0% | |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $68,000 | -20.0% | 127,062 | 0.0% | 0.00% | -40.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SYNAPTICS INC | 24 | Q3 2023 | 7.3% |
| TECHNOLOGY SELECT SECT SPDR | 24 | Q3 2023 | 5.7% |
| SPRINT CORPORATION | 24 | Q3 2023 | 5.1% |
| VANGUARD INDEX FDS | 24 | Q3 2023 | 6.2% |
| WAVE LIFE SCIENCES LTD | 24 | Q3 2023 | 8.2% |
| ORMAT TECHNOLOGIES INC | 24 | Q3 2023 | 6.8% |
| SOLAREDGE TECHNOLOGIES INC | 24 | Q3 2023 | 4.5% |
| SEI INVESTMENTS CO | 24 | Q3 2023 | 3.4% |
| SWITCH INC | 24 | Q3 2023 | 3.6% |
| FIRST TRUST US EQUITY OPPORT | 24 | Q3 2023 | 2.1% |
View MEITAV INVESTMENT HOUSE LTD's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CollPlant Biotechnologies Ltd | July 24, 2023 | 492,619 | 5.0% |
| Finnovate Acquisition Corp.Sold out | May 24, 2023 | 0 | 0.0% |
| PARTNER COMMUNICATIONS CO LTD | January 11, 2023 | 15,704,244 | 8.4% |
| Intec Pharma Ltd. | November 04, 2020 | 120,816 | 3.1% |
| KAMADA LTD | February 18, 2020 | 2,090,149 | 5.0% |
| Anchiano Therapeutics Ltd. | November 18, 2019 | 1,806,577 | 4.9% |
| Itamar Medical Ltd. | September 12, 2019 | 16,058,196 | 4.8% |
| Can-Fite BioPharma Ltd. | May 13, 2019 | 1,908,756 | 3.5% |
| Foresight Autonomous Holdings Ltd. | March 20, 2019 | 7 | 4.6% |
| B COMMUNICATIONS LTD | January 15, 2019 | 499 | 5.0% |
View MEITAV INVESTMENT HOUSE LTD's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-05-06 |
| 13F-HR | 2024-05-01 |
| SC 13G/A | 2024-03-25 |
| 13F-HR | 2024-01-29 |
| SC 13G/A | 2024-01-09 |
| SC 13G/A | 2024-01-09 |
| 13F-HR | 2023-10-30 |
| SC 13G/A | 2023-08-17 |
| 13F-HR/A | 2023-08-10 |
| SC 13G/A | 2023-08-07 |
View MEITAV INVESTMENT HOUSE LTD's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.